Sinopharm Group Co Ltd operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sinopharm Group Co Ltd with three other
drug stores in Asia:
Alfresa Holdings Corporation
sales of 2.58 trillion Japanese Yen [US$23.16 billion]
of which 88%
was Wholesale Business of Pharmaceuticals fo),
Medipal Holdings Corporation
(3.03 trillion Japanese Yen [US$27.22 billion]
of which 70%
was Pharmaceuticals And Food Precessing Whol), and
Suzuken Co., Ltd.
based in Japan
(2.23 trillion Japanese Yen [US$20.03 billion]
of which 93%
was Pharmaceutical Wholesale Business).
During the year ended December of 2016, sales at
Sinopharm Group Co Ltd were 258.39 billion Chinese Renmimbi (US$38.18 billion).
increase of 13.8%
versus 2015, when the company's sales were 227.07 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Sinopharm Group Co Ltd
(and since 2011, sales have increased a total of 153%).
Sales of Retail Pharmacy Operations saw an increase
17.1% in 2016, from
8.71 billion Chinese Renmimbi to 10.20 billion Chinese Renmimbi.
Not all segments of Sinopharm Group Co Ltd experienced an increase in sales in 2016:
sales of Other Business Operations fell 1.3% to 4.30 billion Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).